药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Enprofylline
Tocilizumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Tocilizumab.
Enprofylline
Canakinumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Canakinumab.
Enprofylline
Apremilast
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Apremilast.
Enprofylline
Human interferon omega-1
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Human interferon omega-1.
Enprofylline
Briakinumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Briakinumab.
Enprofylline
Gallium nitrate
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Gallium nitrate.
Enprofylline
Glatiramer
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Glatiramer.
Enprofylline
Interferon alfa
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Interferon alfa.
Enprofylline
Afelimomab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Afelimomab.
Enprofylline
Pirfenidone
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Pirfenidone.
Enprofylline
Aldosterone
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Aldosterone.
Enprofylline
Brequinar
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Brequinar.
Enprofylline
2-Methoxyethanol
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with 2-Methoxyethanol.
Enprofylline
Vorinostat
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Vorinostat.
Enprofylline
Castanospermine
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Castanospermine.
Enprofylline
Hydroxychloroquine
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Hydroxychloroquine.
Enprofylline
Stepronin
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Stepronin.
Enprofylline
Ciclesonide
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Ciclesonide.
Enprofylline
Paramethasone
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Paramethasone.
Enprofylline
Cortisone acetate
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Cortisone acetate.